Can a genetic test make warfarin safer for black patients?

NCT ID NCT03225820

First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 22 times

Summary

This study looks at whether giving doctors and pharmacists genetic information about their African American patients can help them prescribe medications more safely, especially the blood thinner warfarin. About 1,000 African American adults will take part. The goal is to see if this approach leads to better health outcomes and reduces medication risks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFORMATION SEEKING BEHAVIOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Northwestern University

    NOT_YET_RECRUITING

    Chicago, Illinois, 60611, United States

    Contact Phone: •••-•••-••••

  • The University of Illinois at Chicago

    RECRUITING

    Chicago, Illinois, 60607, United States

    Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.